Press Releases

Date	Title	PDF Version
Apr 11, 2014	Researchers to Present New Data on Asfotase Alfa in Infants and Juveniles with Hypophosphatasia at the Joint Meeting of the Pediatric Academic Societies and the Asian Society for Pediatric Research
Apr 10, 2014	Alexion Pharmaceuticals to Report First Quarter 2014 Results on Thursday, April 24, 2014
Mar 10, 2014	Alexion Revises Upward 2014 Financial Guidance for Revenues and non-GAAP EPS
Mar 05, 2014	Alexion to Present at the Barclays Global Healthcare Conference
Mar 03, 2014	NICE Confirms AGNSS Positive Assessment that Eculizumab (Soliris®) is a Very Effective Treatment for aHUS Patients and Produces Substantial Quality-Adjusted Life Year Gains of a Magnitude Rarely Seen for a New Drug
Feb 28, 2014	Alexion Joins Patient Organizations Worldwide in Recognizing Rare Disease Day 2014
Feb 25, 2014	Alexion to Present at the Cowen and Company 34th Annual Health Care Conference
Feb 24, 2014	European Commission Grants Orphan Drug Designation to Soliris® (Eculizumab) for Prevention of Delayed Graft Function (DGF) after Solid Organ Transplantation
Jan 30, 2014	Alexion Reports Fourth Quarter and Full Year 2013 Results and Provides Financial Guidance for 2014
Jan 21, 2014	FDA Grants Orphan Drug Designation to Soliris® (eculizumab) for Prevention of Delayed Graft Function (DGF) in Renal Transplant Patients

Search